Stephens Inc Abb Vie Inc. Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

A detailed history of Stephens Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Stephens Inc holds 160,463 shares of ABBV stock, worth $32.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

160,463

Previous 146,237 9.73%

Holding current value

$32.2 Million

Previous $25.1 Million 26.34%

% of portfolio

0.47%

Previous 0.4%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$163.84 - $199.33 $2.33 Million - $2.84 Million	14,226 Added 9.73%	160,463 $31.7 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $875,647 - $1.02 Million	-5,657 Reduced 3.72%	146,237 $25.1 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.44 Million - $1.64 Million	-9,002 Reduced 5.59%	151,894 $27.7 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $357,347 - $402,457	-2,597 Reduced 1.59%	160,896 $24.9 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $1.21 Million - $1.4 Million	-9,050 Reduced 5.25%	163,493 $24.4 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $2.11 Million - $2.63 Million	-15,921 Reduced 8.45%	172,543 $23.2 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $929,119 - $1.07 Million	-6,425 Reduced 3.3%	188,464 $30 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $971,904 - $1.17 Million	7,027 Added 3.74%	194,889 $31.5 Million
Q3 2022 Nov 02, 2022	SELL	$134.21 - $153.93 $2.1 Million - $2.41 Million	-15,639 Reduced 7.68%	187,862 $25.2 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $245,789 - $312,478	-1,786 Reduced 0.87%	203,501 $31.2 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $2.58 Million - $3.2 Million	-19,517 Reduced 8.68%	205,287 $33.3 Million
Q4 2021 Mar 07, 2022	SELL	$107.43 - $135.93 $4.97 Million - $6.29 Million	-46,308 Reduced 17.08%	224,804 $30.4 Million
Q3 2021 Oct 27, 2021	SELL	$106.4 - $120.78 $258,764 - $293,736	-2,432 Reduced 0.89%	271,112 $29.2 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $1.1 Million - $1.22 Million	10,410 Added 3.96%	273,544 $30.8 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $791,699 - $871,566	7,739 Added 3.03%	263,134 $28.5 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $78,477 - $105,953	-975 Reduced 0.38%	255,395 $27.4 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $306,526 - $359,761	-3,568 Reduced 1.37%	256,370 $22.5 Million
Q2 2020 Aug 24, 2020	BUY	$73.37 - $98.18 $234,563 - $313,881	3,197 Added 1.25%	259,938 $25.5 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $1.73 Million - $2.62 Million	-26,757 Reduced 9.44%	256,741 $19.6 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $381,207 - $476,971	-5,285 Reduced 1.83%	283,498 $25.1 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $3.04 Million - $3.65 Million	48,234 Added 20.05%	288,783 $21.9 Million
Q2 2019 Aug 01, 2019	BUY	$65.7 - $83.98 $2.37 Million - $3.03 Million	36,043 Added 17.62%	240,549 $17.5 Million
Q1 2019 May 03, 2019	BUY	$77.14 - $90.79 $1.84 Million - $2.17 Million	23,893 Added 13.23%	204,506 $16.5 Million
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $2.82 Million - $3.48 Million	36,197 Added 25.06%	180,613 $16.7 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.93 Million - $2.14 Million	-21,661 Reduced 13.04%	144,416 $13.7 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $1.57 Million - $1.86 Million	-17,482 Reduced 9.52%	166,077 $15.4 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $6.93 Million - $9.28 Million	-75,317 Reduced 29.09%	183,559 $17.4 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $5.32 Million - $5.83 Million	-59,411 Reduced 18.67%	258,876 $25 Million
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $3.39 Million - $4.33 Million	-48,531 Reduced 13.23%	318,287 $28.3 Million
Q2 2017 Aug 10, 2017	BUY	N/A	366,818	366,818 $26.6 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account